According to industry leaders like @Medtronic, half of neurosurgery will be in #ASC. As educators we must embrace/ lead this effort as we educate our next generation surgeons. Here is our pub @NeurosurgeryCNS@HCAhealthcare@CNS_Update@AANSNeuro
https://t.co/Z7ZfR3ciUd
Giant aneurysm treated with FRED-X using @q_apel Walrus for stability and safety.
Key points:
1. #sail technique to pass 360 turn
2.. Large 24 micro wire
3. Conscious sedation
4. Long flow diverter
@MV_Terumo @kunalraygor@ubnsvascular@CNS_Update@cvsection
People ask what is our identity @UB_Neurosurgery . Nick Hopkins built this program on a foundation of family values and #innovation. We doubled down , adding sub-speciality clinical expertise, research trials, and #volume. Training for the neurosurgery of tomorrow, #NOW!
If high volume clinical cases, many peer reviewed publications, and the latest technology and trials are of interest- this is THE fellowship for potential endovascular /open vascular enthusiasts . The best part is the #BuffaloMafia , a growing family of thought leaders!
Personal thanks to Mr. Mark Dellas and @AidanRyan for their eloquence and storytelling craftsmanship. Our shared neurosurgical future is no longer limited by technology, rather only by what we dare to imagine. @UB_Neurosurgery@UBuffalo@CNS_Update
I am incredibly pleased and honored to announce the below scholarship. Through the generosity of two prior fellows, Georgia medical students can receive funding to experience what great things we are doing at @UB_Neurosurgery.
Thanks @DavidSmolarMD and Bobby! @EladLevyMD
Always grateful for the life lessons learned in the classrooms and around the boathouse @goChoate. The academic rigor and cultivation of #intellectual#curiosity are foundational to the campus #culture. Thank you for the story.
https://t.co/V5vN9kYg60
Strong work by Dr. Guthikonda and the team @LSUHS looking at l training volumes. For #match2024 applicants, some metrics to consider.
Fact: @UB_Neurosurgery does 13k plus cases annually.
Also fact : Our residents round at the same time as most other programs!
InspireMD Announces Strategic Agreement with The @JacobsInstitute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions.
Click here for full details: https://t.co/Y28fDfJJkj
#stroke@_AdnanSiddiqui#Acutestroke